Being chaperoned by csGRP78 for lysosomal degradation, BACE2 silencing suppressed in vitro and in vivo tumorigenesis capability of glioma stem cells, demonstrating that csGRP78 engages in the regulation of cancer stemness in glioma [110]. This evidence concerns the gene BACE2 and central nervous system cancer.